| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |